U.S. markets closed
  • S&P Futures

    4,240.00
    +8.50 (+0.20%)
     
  • Dow Futures

    33,842.00
    +83.00 (+0.25%)
     
  • Nasdaq Futures

    14,295.25
    +32.25 (+0.23%)
     
  • Russell 2000 Futures

    2,307.50
    +7.20 (+0.31%)
     
  • Crude Oil

    73.26
    +0.18 (+0.25%)
     
  • Gold

    1,778.90
    -4.50 (-0.25%)
     
  • Silver

    25.98
    -0.13 (-0.50%)
     
  • EUR/USD

    1.1935
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.4870
    +0.0150 (+1.02%)
     
  • Vix

    16.32
    -0.34 (-2.04%)
     
  • GBP/USD

    1.3962
    -0.0002 (-0.01%)
     
  • USD/JPY

    111.0010
    +0.0390 (+0.04%)
     
  • BTC-USD

    33,142.82
    -726.39 (-2.14%)
     
  • CMC Crypto 200

    796.16
    -14.03 (-1.73%)
     
  • FTSE 100

    7,074.06
    -15.95 (-0.22%)
     
  • Nikkei 225

    28,881.35
    +6.46 (+0.02%)
     

Biotech markets could be ‘very promising’ in 2019

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Even though biotech markets are “down big this year,” Managing Director Mitchell Ng of Thessalus Capital says that there are “specific industries within the healthcare sector that are very promising,” such as gene editing companies. Yahoo Finance’s Alexis Christoforous speaks to him about the future for biotech in 2019.